CJC-1295 is a synthetic peptide believed to function as a growth hormone-releasing hormone (GHRH) analog. It is structurally designed to increase the half-life of endogenous growth hormone-releasing ...
New peptide research blend shows promise as a game-changer in the fitness space BURTON, MI, UNITED STATES, January 19, 2026 /EINPresswire.com/ — Javelin Sciences, a ...
Peptides have emerged as a central focus of study in various sectors due to the wide variety of biological actions that they are capable of. CJC-1295 and Ipamorelin, in particular, have garnered much ...
This groundbreaking formulation now incorporates Sermorelin alongside the original trio of Ipamorelin, CJC-1295 (no DAC), and HGH Fragment 176-191—marking the first commercially available quad-peptide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results